Institutional investors purchased a net $8.2 million shares of ILMN during the quarter ended December 2013 and now own 118.75% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VIKING GLOBAL INVESTORS LP Bought 5.4 Million shares of Illumina Inc
PYRAMIS GLOBAL ADVISORS (CANADA)... Bought 13.5 Thousand shares of Illumina Inc
SIVIK GLOBAL HEALTHCARE LLC Bought 10.0 Thousand shares of Illumina Inc